CXCL13 and rheumatoid arthritis: However, recent studies have shown that in RA patients, CXCR5 levels on the surface of B cells are reduced and that the migration of RA B10 cells into CXCL13‐rich synovial fluid (SF) is reduced, promoting an inflammatory response in the joint.19